{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:04:37Z","timestamp":1790964277772,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T00:00:00Z","timestamp":1238112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00432-009-0576-6","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T01:08:48Z","timestamp":1238029728000},"page":"1351-1358","source":"Crossref","is-referenced-by-count":18,"title":["B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?"],"prefix":"10.1007","volume":"135","author":[{"given":"Petra","family":"Richter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Tost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelore","family":"Altendorf-Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Borsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig","family":"Kosmehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Berndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,27]]},"reference":[{"key":"576_CR1","first-page":"3289","volume":"62","author":"M Adams","year":"2002","unstructured":"Adams M, Jones JL, Walker RA, Pringle JH, Bell SC (2002) Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res 62:3289\u20133297","journal-title":"Cancer Res"},{"key":"576_CR2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.amjcard.2004.07.156","volume":"94","author":"N Aso","year":"2004","unstructured":"Aso N, Tamura A, Nasu M (2004) Circulating tenascin-C levels in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 94:1468\u20131470. doi: 10.1016\/j.amjcard.2004.07.156","journal-title":"Am J Cardiol"},{"key":"576_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-5793(93)80479-E","volume":"332","author":"E Balza","year":"1993","unstructured":"Balza E, Siri A, Ponassi M, Caocci F, Linnala A, Virtanen I, Zardi L (1993) Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin. FEBS Lett 332:39\u201343. doi: 10.1016\/0014-5793(93)80479-E","journal-title":"FEBS Lett"},{"key":"576_CR4","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/molehr\/5.11.1066","volume":"5","author":"SC Bell","year":"1999","unstructured":"Bell SC, Pringle JH, Taylor DJ, Malak TM (1999) Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes. Mol Hum Reprod 5:1066\u20131076. doi: 10.1093\/molehr\/5.11.1066","journal-title":"Mol Hum Reprod"},{"key":"576_CR5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00432-006-0106-8","volume":"132","author":"A Berndt","year":"2006","unstructured":"Berndt A, Anger K, Richter P, Borsi L, Brack S, Silacci M, Franz M, Wunderlich H, Gajda M, Zardi L, Neri D, Kosmehl H (2006) Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder. J Cancer Res Clin Oncol 132:537\u2013546. doi: 10.1007\/s00432-006-0106-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"576_CR6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ijc.2910520504","volume":"52","author":"L Borsi","year":"1992","unstructured":"Borsi L, Carnemolla B, Nicolo G, Spina B, Tanara G, Zardi L (1992) Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 52:688\u2013692. doi: 10.1002\/ijc.2910520504","journal-title":"Int J Cancer"},{"key":"576_CR7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ijc.10662","volume":"102","author":"L Borsi","year":"2002","unstructured":"Borsi L, Balza E, Bestagno M, Castellani P, Carnemolla B, Biro A, Leprini A, Sepulveda J, Burrone O, Neri D, Zardi L (2002) Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. Int J Cancer 102:75\u201385. doi: 10.1002\/ijc.10662","journal-title":"Int J Cancer"},{"key":"576_CR8","first-page":"2796","volume":"43","author":"MA Bourdon","year":"1983","unstructured":"Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD (1983) Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 43:2796\u20132805","journal-title":"Cancer Res"},{"key":"576_CR9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jcp.2004.016576","volume":"57","author":"A Brunner","year":"2004","unstructured":"Brunner A, Mayerl C, Tzankov A, Verdorfer I, Tschorner I, Rogatsch H, Mikuz G (2004) Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer. J Clin Pathol 57:927\u2013931. doi: 10.1136\/jcp.2004.016576","journal-title":"J Clin Pathol"},{"key":"576_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2230.2003.01326.x","volume":"28","author":"ER Burchardt","year":"2003","unstructured":"Burchardt ER, Hein R, Bosserhoff AK (2003) Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma. Clin Exp Dermatol 28:515\u2013520. doi: 10.1046\/j.1365-2230.2003.01326.x","journal-title":"Clin Exp Dermatol"},{"key":"576_CR11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0002-9440(10)65388-6","volume":"154","author":"B Carnemolla","year":"1999","unstructured":"Carnemolla B, Castellani P, Ponassi M, Borsi L, Urbini S, Nicolo G, Dorcaratto A, Viale G, Winter G, Neri D, Zardi L (1999) Identification of a glioblastoma-associated tenascin-C isoform by a high-affinity recombinant antibody. Am J Pathol 154:1345\u20131352","journal-title":"Am J Pathol"},{"key":"576_CR12","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1083\/jcb.98.6.1926","volume":"98","author":"M Chiquet","year":"1984","unstructured":"Chiquet M, Fambrough DM (1984a) Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol 98:1926\u20131936. doi: 10.1083\/jcb.98.6.1926","journal-title":"J Cell Biol"},{"key":"576_CR13","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1083\/jcb.98.6.1937","volume":"98","author":"M Chiquet","year":"1984","unstructured":"Chiquet M, Fambrough DM (1984b) Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol 98:1937\u20131946. doi: 10.1083\/jcb.98.6.1937","journal-title":"J Cell Biol"},{"key":"576_CR14","first-page":"2576","volume":"9","author":"GC Durkan","year":"2003","unstructured":"Durkan GC, Nutt JE, Marsh C, Rajjayabun PH, Robinson MC, Neal DE, Lunec J, Mellon JK (2003) Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer. Clin Cancer Res 9:2576\u20132582","journal-title":"Clin Cancer Res"},{"key":"576_CR15","volume-title":"World Health Organization classification of tumours. pathology and genetics of male genital organs","author":"JN Eble","year":"2004","unstructured":"Eble JN, Sauter G, Epstein JE, Sesterhenn IA (2004) World Health Organization classification of tumours. pathology and genetics of male genital organs. IARC Press, Lyon"},{"key":"576_CR16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/311267a0","volume":"311","author":"HP Erickson","year":"1984","unstructured":"Erickson HP, Inglesias JL (1984) A six-armed oligomer isolated from cell surface fibronectin preparations. Nature 311:267\u2013269. doi: 10.1038\/311267a0","journal-title":"Nature"},{"key":"576_CR17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/path.1935","volume":"208","author":"I Esposito","year":"2006","unstructured":"Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess H, Schirmacher P (2006) Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208:673\u2013685. doi: 10.1002\/path.1935","journal-title":"J Pathol"},{"key":"576_CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00240-002-0280-3","volume":"30","author":"A Hegele","year":"2003","unstructured":"Hegele A, Heidenreich A, Varga Z, von Knobloch R, Olbert P, Kropf J, Hofmann R (2003) Cellular fibronectin in patients with transitional cell carcinoma of the bladder. Urol Res 30:363\u2013366","journal-title":"Urol Res"},{"key":"576_CR19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<475::AID-PATH462>3.0.CO;2-V","volume":"189","author":"W Hindermann","year":"1999","unstructured":"Hindermann W, Berndt A, Borsi L, Luo X, Hyckel P, Katenkamp D, Kosmehl H (1999) Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma. J Pathol 189:475\u2013480. doi: 10.1002\/(SICI)1096-9896(199912)189:4<475::AID-PATH462>3.0.CO;2-V","journal-title":"J Pathol"},{"key":"576_CR20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ndt\/17.6.1005","volume":"17","author":"JH Horstrup","year":"2002","unstructured":"Horstrup JH, Gehrmann M, Schneider B, Ploger A, Froese P, Schirop T, Kampf D, Frei U, Neumann R, Eckardt KU (2002) Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease. Nephrol Dial Transplant 17:1005\u20131013. doi: 10.1093\/ndt\/17.6.1005","journal-title":"Nephrol Dial Transplant"},{"key":"576_CR21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1464-410X.2005.05357.x","volume":"95","author":"E Ioachim","year":"2005","unstructured":"Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Salmas M, Malamou-Mitsi V (2005) A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma. BJU Int 95:655\u2013659. doi: 10.1111\/j.1464-410X.2005.05357.x","journal-title":"BJU Int"},{"issue":"Pt 2","key":"576_CR22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1242\/jcs.108.2.519","volume":"108","author":"PL Jones","year":"1995","unstructured":"Jones PL, Boudreau N, Myers CA, Erickson HP, Bissell MJ (1995) Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells: localization of active regions using recombinant tenascin fragments. J Cell Sci 108(Pt 2):519\u2013527","journal-title":"J Cell Sci"},{"key":"576_CR23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/path.1589","volume":"203","author":"K Katenkamp","year":"2004","unstructured":"Katenkamp K, Berndt A, Hindermann W, Wunderlich H, Haas KM, Borsi L, Zardi L, Kosmehl H (2004) mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma. J Pathol 203:771\u2013779. doi: 10.1002\/path.1589","journal-title":"J Pathol"},{"key":"576_CR24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijom.2007.04.002","volume":"36","author":"AJ Lyons","year":"2007","unstructured":"Lyons AJ, Jones J (2007) Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int J Oral Maxillofac Surg 36:671\u2013679. doi: 10.1016\/j.ijom.2007.04.002","journal-title":"Int J Oral Maxillofac Surg"},{"key":"576_CR25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.urology.2004.09.028","volume":"65","author":"V Menendez","year":"2005","unstructured":"Menendez V, Fernandez-Suarez A, Galan JA, Perez M, Garcia-Lopez F (2005) Diagnosis of bladder cancer by analysis of urinary fibronectin. Urology 65:284\u2013289. doi: 10.1016\/j.urology.2004.09.028","journal-title":"Urology"},{"key":"576_CR26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1097-0215(19970717)72:2<236::AID-IJC6>3.0.CO;2-S","volume":"72","author":"AJ Mighell","year":"1997","unstructured":"Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA (1997) Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer 72:236\u2013240. doi: 10.1002\/(SICI)1097-0215(19970717)72:2<236::AID-IJC6>3.0.CO;2-S","journal-title":"Int J Cancer"},{"key":"576_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1464-410X.2003.04020.x","volume":"91","author":"JE Nutt","year":"2003","unstructured":"Nutt JE, Durkan GC, Mellon JK, Lunec J (2003) Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine. BJU Int 91:99\u2013104. doi: 10.1046\/j.1464-410X.2003.04020.x","journal-title":"BJU Int"},{"key":"576_CR28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0022-5347(01)61684-7","volume":"161","author":"E Ozdemir","year":"1999","unstructured":"Ozdemir E, Kakehi Y, Okuno H, Yoshida O (1999) Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas. J Urol 161:1359\u20131363. doi: 10.1016\/S0022-5347(01)61684-7","journal-title":"J Urol"},{"key":"576_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jchromb.2007.06.001","volume":"856","author":"M Papale","year":"2007","unstructured":"Papale M, Pedicillo MC, Thatcher BJ, Di Paolo S, Lo Muzio L, Bufo P, Rocchetti MT, Centra M, Ranieri E, Gesualdo L (2007) Urine profiling by SELDI-TOF\/MS: monitoring of the critical steps in sample collection, handling and analysis. J Chromatogr B Analyt Technol Biomed Life Sci 856:205\u2013213. doi: 10.1016\/j.jchromb.2007.06.001","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"576_CR30","first-page":"3093","volume":"22","author":"C Pauli","year":"2002","unstructured":"Pauli C, Stieber P, Schmitt UM, Andratschke M, Hoffmann K, Wollenberg B (2002) The significance of tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck. Anticancer Res 22:3093\u20133097","journal-title":"Anticancer Res"},{"key":"576_CR31","doi-asserted-by":"crossref","unstructured":"Richter P, Junker K, Franz M, Berndt A, Geyer C, Gajda M, Kosmehl H, Wunderlich H (2008) IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC). J Cancer Res Clin Oncol [Epub]","DOI":"10.1007\/s00432-008-0390-6"},{"key":"576_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ijc.2910640113","volume":"64","author":"S Riedl","year":"1995","unstructured":"Riedl S, Bodenmuller H, Hinz U, Holle R, Moller P, Schlag P, Herfarth C, Faissner A (1995) Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int J Cancer 64:65\u201369. doi: 10.1002\/ijc.2910640113","journal-title":"Int J Cancer"},{"key":"576_CR33","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/01.ju.0000049201.91150.9d","volume":"169","author":"MH Sherief","year":"2003","unstructured":"Sherief MH, Low SH, Miura M, Kudo N, Novick AC, Weimbs T (2003) Matrix metalloproteinase activity in urine of patients with renal cell carcinoma leads to degradation of extracellular matrix proteins: possible use as a screening assay. J Urol 169:1530\u20131534. doi: 10.1097\/01.ju.0000049201.91150.9d","journal-title":"J Urol"},{"key":"576_CR34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/protein\/gzl033","volume":"19","author":"M Silacci","year":"2006","unstructured":"Silacci M, Brack SS, Spath N, Buck A, Hillinger S, Arni S, Weder W, Zardi L, Neri D (2006) Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo. Protein Eng Des Sel 19:471\u2013478. doi: 10.1093\/protein\/gzl033","journal-title":"Protein Eng Des Sel"},{"key":"576_CR35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1253\/circj.71.327","volume":"71","author":"F Terasaki","year":"2007","unstructured":"Terasaki F, Okamoto H, Onishi K, Sato A, Shimomura H, Tsukada B, Imanaka-Yoshida K, Hiroe M, Yoshida T, Kitaura Y, Kitabatake A (2007) Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy. Circ J 71:327\u2013330. doi: 10.1253\/circj.71.327","journal-title":"Circ J"},{"key":"576_CR36","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)64320-9","volume":"162","author":"T Tsunoda","year":"2003","unstructured":"Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, Katsuta K, Sakakura T, Majima Y, Yoshida T (2003) Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol 162:1857\u20131867","journal-title":"Am J Pathol"},{"key":"576_CR37","first-page":"669","volume":"8","author":"H Wunderlich","year":"2001","unstructured":"Wunderlich H, Reichelt O, Zermann DH, Schubert J, Berndt A, Kosmehl H (2001) Fetal fibronectin: a new screening marker for bladder cancer? Oncol Rep 8:669\u2013672","journal-title":"Oncol Rep"},{"key":"576_CR38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0009-9120(94)00079-B","volume":"28","author":"S Ylatupa","year":"1995","unstructured":"Ylatupa S, Mertaniemi P, Haglund C, Partanen P (1995) Enzyme immunoassay for quantification of tenascin in biologic samples. Clin Biochem 28:263\u2013268. doi: 10.1016\/0009-9120(94)00079-B","journal-title":"Clin Biochem"},{"key":"576_CR39","first-page":"127","volume":"13","author":"R Yoshimura","year":"2004","unstructured":"Yoshimura R, Wada S, Matsuyama M, Hase T, Goto T, Tanaka T, Kuratsukuri K, Tsuchida K, Nakatani T (2004) Urinary extracellular matrix measurement as a reliable and cost-effective diagnostic tool for bladder tumors. Int J Mol Med 13:127\u2013131","journal-title":"Int J Mol Med"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0576-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-009-0576-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0576-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T12:11:29Z","timestamp":1633263089000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-009-0576-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,27]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1007\/s00432-009-0576-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,27]]}}}